Close Window

Digital Look Email A Friend

Biogen to buy Apellis Pharmaceuticals in $5.6bn deal

Published by Michele Maatouk on 31st March 2026

(Sharecast News) - Shares in Apellis Pharmaceuticals rocketed on Tuesday after it agreed to be bought by Biogen in a $5.6bn deal.

URL: http://www.digitallook.com/dl/news/story/35825835/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.